Medical-Grade Activated Charcoal Manufacturing and Formulation

The contract calls for the manufacture of a medical-grade activated charcoal suspension at a concentration of 50 grams per 240 milliliters, specifically for use in military medical supply chains. The product must fully comply with United States Pharmacopeia standards, current good manufacturing practices, and stringent stability requirements to ensure safety, efficacy, and longevity under operational storage conditions. Production must be conducted in a facility capable of maintaining consistent quality control throughout formulation, processing, and packaging to meet the demanding specifications of a defense medical application. The procurement is structured as a subcontract under the Department of Defense’s Medical Supply Chain PHSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, indicating a narrow timeframe for submission. The NAICS code 325412 identifies the industry as pharmaceutical preparation manufacturing, reinforcing the regulatory and technical rigor expected from the supplier. All aspects of production, from raw material sourcing to final product release, must align with federal medical supply protocols to ensure seamless integration into military medical operations.